by Portfolio Grader | March 28, 2014 8:15 am
This week, these five stocks have the best ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
Lannett Company, Inc. (LCI) manufactures and distributes pharmaceutical products under its own trade name and under generic names. LCI also gets A’s in Earnings Growth, Earnings Momentum, Earnings Surprises, Operating Margin Growth and Sales Growth. For more information, get Portfolio Grader’s complete analysis of LCI stock.
RESI also gets an A in Earnings Surprises. For more information, get Portfolio Grader’s complete analysis of RESI stock.
Sucampo Pharmaceuticals, Inc. Class A (SCMP) is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. SCMP also gets A’s in Equity, Cash Flow and Sales Growth. For more information, get Portfolio Grader’s complete analysis of SCMP stock.
SMART Technologies Inc. Class A (SMT) designs, develops and sells interactive technology solutions. SMT also gets A’s in Earnings Momentum and Cash Flow. Shares of the stock have risen 138.1% since January 1. This is better than the Nasdaq, which has remained flat. For more information, get Portfolio Grader’s complete analysis of SMT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
Source URL: https://investorplace.com/2014/03/5-stocks-with-prime-analyst-earnings-revisions-lci-nbg-pa-resi-scmp-smt-lci-nbg-pa-resi/
Short URL: http://invstplc.com/1hCFOtD
Copyright ©2017 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.